1. Speroff L, Fritz M (2004) Clinical gynecologic endocrinology and infertility, 7th edn. Lippincott Williams & Wilkins, Baltimore, pp 575–593
2. Reid P, Virtanen-Kari S (2005) Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts. BJOG 112(8):1121–1125
3. Milsom I, Andersson K, Andersch B, Rybo G (1991) A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia. Am J Obstet Gynecol 164:879–883
4. Kari S (2005) Randomized, open-label, multicenter study comparing the efficacy and safety of Mirena to a 3-month administration of danazol followed by a 3-month observation period in women aged over 30 with functional menorrhagia: Berlex Canada; Report No.: A00696/DE00650-303003. Data on file
5. Endrikat J, Shapiro H, Lukkari-Lax E, Kunz M, Schmidt W, Fortier M (2009) A Canadian, multicentre study comparing the efficacy of a levonorgestrel-releasing intrauterine system to an oral contraceptive in women with idiopathic menorrhagia. JOGC 31:340–347